<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="48717">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02062528</url>
  </required_header>
  <id_info>
    <org_study_id>DCIC 13 15</org_study_id>
    <nct_id>NCT02062528</nct_id>
  </id_info>
  <brief_title>Hot Flashes and Omega 3</brief_title>
  <acronym>BOOM3</acronym>
  <official_title>Evaluation de l'efficacité Des Acides Gras oméga 3 Hautement concentrés en EPA Sur Les bouffées de Chaleur, Chez Des Femmes en période de péri-ménopause et ménopause : étude Monocentrique, en Groupes parallèles, contrôlée, randomisée vs Placebo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vivatech</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Centre d'Investigation Clinique de Grenoble CIC1406</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Vivatech</source>
  <oversight_info>
    <authority>France: ANSM - French Health Products Safety Agency</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective is to evaluate the effects of omega-3 fatty acids on hot flashes
      frequency.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">April 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>hot flashes frequency</measure>
    <time_frame>1 to 8 week</time_frame>
    <safety_issue>No</safety_issue>
    <description>ANOVA by repeated measures</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>hot flashes frequency difference</measure>
    <time_frame>4 week and 8 week</time_frame>
    <safety_issue>No</safety_issue>
    <description>difference betwwen week8 and week4 and week0</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>diurnal hot flashes</measure>
    <time_frame>week 1 to 8</time_frame>
    <safety_issue>No</safety_issue>
    <description>ANOVA and difference</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>night hot flashes</measure>
    <time_frame>week 1 to 8</time_frame>
    <safety_issue>No</safety_issue>
    <description>ANOVA and difference</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>vasomotors disorders</measure>
    <time_frame>week 1 to  week 8</time_frame>
    <safety_issue>No</safety_issue>
    <description>ANOVA and differences</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pittsburgh Sleep Quality Index (PSQI)</measure>
    <time_frame>week 0 and week 8</time_frame>
    <safety_issue>No</safety_issue>
    <description>sleep quality</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HFRDIS</measure>
    <time_frame>week 0 and week 8</time_frame>
    <safety_issue>No</safety_issue>
    <description>quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Menopause-Specific Quality of Life (MENQOL)</measure>
    <time_frame>week 0 and week 8</time_frame>
    <safety_issue>No</safety_issue>
    <description>quality of life</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Weight</measure>
    <time_frame>week 0 and week 8</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fatty acids dosage</measure>
    <time_frame>week 0 and week 8</time_frame>
    <safety_issue>No</safety_issue>
    <description>fatty acids dosage</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>number of adverse events</measure>
    <time_frame>week 0 to week 8</time_frame>
    <safety_issue>Yes</safety_issue>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">136</enrollment>
  <condition>Hot Flashes</condition>
  <condition>Fatty Acids</condition>
  <condition>Menopause</condition>
  <arm_group>
    <arm_group_label>omega-3 fatty acids</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>3 capsules each day during 8 weeks</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>3 capsules each day during 8 weeks</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>omega-3 fatty acids</intervention_name>
    <description>highly dosed in EPA</description>
    <arm_group_label>omega-3 fatty acids</arm_group_label>
    <other_name>groupe actif</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  menopause or peri menopause

          -  complaining of hot flashes

          -  social security affiliation

          -  informed consent form signed

        Exclusion Criteria:

          -  primary pathology which can lead to hot flashes

          -  allergy to omega-3 fatty acids

          -  allergy to sea products

          -  High consumption of fat fish or produced by the sea

          -  iatrogenic hot flashes

          -  actual omega-3 fatty acids consumption or in the 3 last months.

          -  consumption of drug or other products for hot flashes in the last month

          -  protected persons (L1121-5 to L1121-8 of French Public health code)
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jean-Luc CRACOWSKI, MD-PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre d'investigation clinique CIC1406</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adeline PARIS, PharmD-PhD</last_name>
    <phone>04-76-76-73-83</phone>
    <email>AParis@chu-grenoble.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Béatrice SPILUTTINI, PhD</last_name>
    <email>BSPILUTTINI@vivatech.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Centre d'investigation clinique CIC1406</name>
      <address>
        <city>GRENOBLE cedex9</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>PARIS Adeline</last_name>
      <phone>33476767383</phone>
      <email>AParis@chu-grenoble.fr</email>
    </contact>
    <investigator>
      <last_name>Jean-Luc CRACOWSKI, MD-PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Claire CRACOWSKI, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 12, 2014</lastchanged_date>
  <firstreceived_date>February 12, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>EPA</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Hot Flashes</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
